Question 48

Vyvanse requires a special risk management program, such as REMS.

Vyvanse is one of the medications that necessitates a Risk Evaluation and Mitigation Strategy (REMS) under federal law, primarily due to the potential for misuse and abuse related to its formulation as a stimulant.

A) Lipitor

Lipitor, a statin used to lower cholesterol, does not require a special risk management program. While it has associated risks, such as liver issues, it is not classified under medications that necessitate REMS.

B) Lidoderm

Lidoderm is a topical anesthetic patch that does not fall under the category of medications requiring a REMS program. Its risk profile does not warrant the same level of monitoring or management as that of controlled substances.

C) Zoloft

Zoloft is an antidepressant that does not require a special risk management program. Although it carries some risks, such as potential side effects related to mental health, it is not classified under medications that necessitate a REMS.

D) Vyvanse

Vyvanse is a central nervous system stimulant used for the treatment of ADHD and requires a REMS program due to its potential for abuse and dependence. This program is designed to mitigate risks associated with its use and ensure patient safety.

Conclusion

Vyvanse is the only medication among the options that mandates a REMS program due to its high abuse potential. In contrast, Lipitor, Lidoderm, and Zoloft do not pose the same level of risk that necessitates such stringent management, making Vyvanse the definitive correct answer.